Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | ZYME | QURE | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Zymeworks Inc | Uniqure N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.30 | 26.21 | 24.30 | ||
| High | 3.35 | 26.21 | 29.49 | ||
| Low | 3.20 | 23.39 | 23.49 | ||
| Latest | 3.32 | 23.89 | 27.66 | ||
| Change | +0.05 | -2.71 | +3.51 | ||
| % Change | +1.53% | -10.19% | +14.53% | ||
| Volume | 13,648,199 | 1,454,500 | 6,719,100 | ||
| 20-Day Average Volume | 11,944,400 | 596,090 | 1,955,815 | ||
| Previous Close | 3.27 | 26.60 | 24.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.50 | 27.31 | 19.19 | ||
| 20-Day Raw Stochastic | 23.68% | 7.86% | 87.01% | ||
| 20-Day Relative Strength | 46.72 | 40.38 | 70.37 | ||
| Weighted Alpha | -35.31 | +77.24 | +27.31 | ||
| Today's Opinion | 72% Sell | 48% Buy | 8% Buy | ||
| Previous Opinion | 72% Sell | 88% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.06% since 05/01/26 | -10.22% since 05/01/26 | +44.59% since 05/01/26 | ||
| Low | 3.14 on 05/06/26 | 23.39 on 05/08/26 | 19.40 on 05/04/26 | ||
| High | 3.56 on 05/05/26 | 27.96 on 05/07/26 | 29.49 on 05/08/26 | ||
| 1-Month | |||||
| %Chg | -2.06% since 04/08/26 | -10.56% since 04/08/26 | +74.07% since 04/08/26 | ||
| Low | 3.14 on 05/06/26 | 23.39 on 05/08/26 | 13.21 on 04/10/26 | ||
| High | 3.90 on 04/16/26 | 29.75 on 04/27/26 | 29.49 on 05/08/26 | ||
| 3-Month | |||||
| %Chg | -16.58% since 02/06/26 | +5.15% since 02/06/26 | +7.84% since 02/06/26 | ||
| Low | 2.80 on 03/30/26 | 21.93 on 02/23/26 | 8.73 on 03/03/26 | ||
| High | 4.09 on 02/10/26 | 29.75 on 04/27/26 | 29.49 on 05/08/26 | ||
| 6-Month | |||||
| %Chg | -28.14% since 11/07/25 | +45.14% since 11/07/25 | -0.47% since 11/07/25 | ||
| Low | 2.80 on 03/30/26 | 16.57 on 11/10/25 | 8.73 on 03/03/26 | ||
| High | 5.24 on 01/22/26 | 29.75 on 04/27/26 | 31.43 on 11/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,750,961 | 1,761,888 | 1,744,406 | ||
| Shares Outstanding, K | 527,398 | 73,750 | 63,066 | ||
| Annual Sales | 74,680,000 | 105,970,000 | 16,100,000 | ||
| Annual Net Income | -644,760,000 | -81,130,000 | -198,970,000 | ||
| Last Quarter Sales | 35,540,000 | 2,510,000 | 5,570,000 | ||
| Last Quarter Net Income | -108,120,000 | -41,210,000 | -37,090,000 | ||
| 60-Month Beta | 1.05 | 1.20 | 0.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 05/06/26 | -0.59 on 05/07/26 | -0.85 on 05/05/26 | ||
| Earnings Date | 08/04/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||